Low PANX1 expression in cancer cells resulted in the release of lower ATP levels in response to chemotherapeutic drug treatment and immunogenicity that was insufficient for promoting dendritic cell maturation, proinflammatory cytokine release, and T-cell-mediated killing in vitro. Here, PANX1 is linked to cancer.